BioSpace News Archive

AB-729, Arbutus’ proprietary subcutaneously delivered RNAi agent, continues to demonstrate robust and continuous declines in hepatitis B surface antigen (HBsAg) in subjects with chronic hepatitis B (HBV) with favorable safety and tolerability data Additional data from the ongoing Phase 1a/1b clinical trial of AB-729, including 60 mg multi-dose data (dosing interval every 4 and 8 weeks) and 90 mg multi-dose data (dosing interval every 8 weeks), expected in 2Q/2021

GC Pharma announced that the United States Food and Drug Administration accepted the company’s Biologics License Application for ‘GC5107,10% Liquid)’ intended for the treatment of Primary Humoral Immunodeficiency, a class of inherited genetic disorders that causes an individual to have a deficient or absent immune system.

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, reported financial results for the quarter ended March 31, 2021 and provided a corporate update.

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces that it has executed an agreement with Takanawa Japan K.K, Pharma Team, for a strategic business development plan to Identify a clinical partner in Japan and other Asian countries for further clinical development of Milciclib for treatment in advanced hepatocellular carcinoma patients.

Tetra Bio-Pharma Inc., a leader in cannabinoid-derived drug discovery and development announced the signing of a Definitive Agreement with DanCann Pharma A/S for the exclusive distribution of Reduvo™ Adversa®, QIXLEEF™ and ENJOUCA™ in Denmark, Norway, Sweden, Finland, and Germany.

Transparency Market Research has published a new report titled, “Veterinary Radiography System Market.” According to the report, the global veterinary radiography system market was valued at US$ 478.1 Mn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027.

Synthetic hormones are man-made hormones produced in a laboratory and are similar to hormones produced by human body

The report details an exhaustive account of the global negative pressure wound therapy market along with numerous associated factors.

Transparency Market Research has published a new report titled ‘Global Heart Pumps Market’. According to the report, the global heart pumps market was valued at approximately US$ 1.8 Bn in 2018. The global heart pumps market is expected to expand at a CAGR of ~10% during the forecast period from 2019 to 2027.

According to the report, the global bone growth stimulators market was valued at US$ 1.3 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.